Abstract:Ageing is a result of gradual and overall functional deteriorations across the body; however, it is unknown whether an individual tissue primarily works to mediate the ageing progress and control lifespan. Here we show that the hypothalamus is important for the development of whole-body ageing in mice, and that the underlying basis involves hypothalamic immunity mediated by IκB kinase-β (IKK-β), nuclear factor κB (NF-κB) and related microglia–neuron immune crosstalk. Several interventional models were developed showing that ageing retardation and lifespan extension are achieved in mice by preventing ageing-related hypothalamic or brain IKK-β and NF-κB activation. Mechanistic studies further revealed that IKK-β and NF-κB inhibit gonadotropin-releasing hormone (GnRH) to mediate ageing-related hypothalamic GnRH decline, and GnRH treatment amends ageing-impaired neurogenesis and decelerates ageing. In conclusion, the hypothalamus has a programmatic role in ageing development via immune–neuroendocrine integration, and immune inhibition or GnRH restoration in the hypothalamus/brain represent two potential strategies for optimizing lifespan and combating ageing-related health problems. Activation of IKK-β and NF-κB in the hypothalamus of mice is shown to accelerate the ageing process, leading to shortened lifespan; inhibition of hypothalamic or brain IKK-β and NF-κB delays ageing and increases lifespan, and NF-κB activation results in a reduction of GnRH levels, whereas NF-κB inhibition leads to GnRH-induced neurogenesis to mediate ageing retardation. Ageing is closely associated with both nutrition and inflammation, and certain neurons can mediate environmental influences on ageing in Caenorhabditis elegans and Drosophila. This study focuses on the hypothalamus, a brain region that is critical for the neuroendocrine interaction between the central nervous system and the periphery. Guo Zhang et al. show that activation of IKK-β and NF-κB in the hypothalamus of mice accelerates the ageing process and shortens lifespan. Inhibition of IKK-β and NF-κB, mediators of metabolic inflammation, delays ageing and extends lifespan. NF-κB activation results in a decline of gonadotropin-releasing hormone (GnRH) levels and suppresses neurogenesis. GnRH treatment amends ageing-impaired neurogenesis and decelerates ageing. These results suggest that NF-κB-mediated inhibition of GnRH may shut down reproduction and ensure the quality of the species, but it initiates systemic ageing at the same time.

Novel small molecule inhibition of IKK/NF‐κB activation reduces markers of senescence and improves healthspan in mouse models of aging

NF-κB inhibition delays DNA damage-induced senescence and aging in mice.

Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretome

Identification of a small molecule SR9009 that activates NRF2 to counteract cellular senescence

Long-term Every-Other-day Administration of DMAMCL Has Little Effect on Aging and Age-Associated Physiological Decline in Mice

The Achilles’ heel of senescent cells: from transcriptome to senolytic drugs

Senolytics improve physical function and increase lifespan in old age

Targeting CK2 eliminates senescent cells and prolongs lifespan in Zmpste24 -deficient mice

Hypothalamic Programming of Systemic Ageing Involving IKK-β, NF-κB and GnRH.

High throughput small molecule screening reveals NRF2-dependent and - independent pathways of cellular stress resistance

Nucleotide‐binding domain and leucine‐rich‐repeat‐containing protein X1 deficiency induces nicotinamide adenine dinucleotide decline, mechanistic target of rapamycin activation, and cellular senescence and accelerates aging lung‐like changes

Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence

Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging

Inhibitor PF-04691502 works as a senolytic to regulate cellular senescence

AAV-mediated expression of secreted and transmembrane αKlotho isoforms rescues relevant aging hallmarks in senescent SAMP8 mice

Sustained activation of NF-κB through constitutively active IKKβ leads to senescence bypass in murine dermal fibroblasts

ATM is a key driver of NF-κB-dependent DNA-damage-induced senescence, stem cell dysfunction and aging

c-Jun N-terminal kinase signaling in aging

NAD+ Repletion Improves Mitochondrial and Stem Cell Function and Enhances Life Span in Mice

The use of progeroid DNA repair-deficient mice for assessing anti-aging compounds, illustrating the benefits of nicotinamide riboside

Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice